Bamanda Biotek Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 29-06-2024
- Paid Up Capital ₹ 1.55 M
as on 29-06-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.20 M
as on 29-06-2024
- Revenue 15.14%
(FY 2020)
- Profit 17.54%
(FY 2020)
- Ebitda -221.47%
(FY 2020)
- Net Worth 18.41%
(FY 2020)
- Total Assets 24.77%
(FY 2020)
About Bamanda Biotek
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.55 M.
The company currently has active open charges totaling ₹5.20 M.
Nirmal Mishra, Satyabhama Biswal, and Niranjan Pradhan serve as directors at the Company.
- CIN/LLPIN
U15400OR2014PTC017971
- Company No.
017971
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bamanda Biotek?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirmal Mishra  | Director | 21-Sep-2018 | Current |
| Satyabhama Biswal | Director | 25-Mar-2014 | Current |
| Niranjan Pradhan | Director | 25-Mar-2014 | Current |
Financial Performance of Bamanda Biotek.
Bamanda Biotek Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 15.14% increase. The company also saw a substantial improvement in profitability, with a 17.54% increase in profit. The company's net worth Soared by an impressive increase of 18.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bamanda Biotek?
In 2020, Bamanda Biotek had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vedic Agro Science Private LimitedActive 15 years 3 monthsSatyabhama Biswal and Niranjan Pradhan are mutual person
- Geon Agro Private LimitedActive 11 years 4 months
Satyabhama Biswal and Niranjan Pradhan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jun 2018 | ₹5.20 M | Open |
How Many Employees Work at Bamanda Biotek?
Bamanda Biotek has a workforce of 0 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bamanda Biotek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bamanda Biotek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
